Agilon Health (Agilon Health) Interest Expense : $-7 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Agilon Health Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Agilon Health's interest expense for the three months ended in Dec. 2023 was $ -2 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was $-7 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Agilon Health's Operating Income for the three months ended in Dec. 2023 was $ -160 Mil. Agilon Health's Interest Expense for the three months ended in Dec. 2023 was $ -2 Mil. Agilon Health did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Agilon Health Interest Expense Historical Data

The historical data trend for Agilon Health's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Agilon Health Interest Expense Chart

Agilon Health Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

-9.07

-8.14

-6.15

-4.48

-6.66

Agilon Health Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Expense	Get a 7-Day Free Trial												-1.67	-1.53	-1.59	-1.65	-1.89

Agilon Health Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7 Mil.

Agilon Health (NYSE:AGL) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Agilon Health's Interest Expense for the three months ended in Dec. 2023 was $-2 Mil. Its Operating Income for the three months ended in Dec. 2023 was $-160 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was $43 Mil.

Agilon Health's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Agilon Health did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Agilon Health (Agilon Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Agilon Health Inc (NYSE:AGL) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

6210 E. US Highway 290, Suite 450, Austin, TX, USA, 78723

Website

https://www.agilonhealth.com

Agilon Health Inc is transforming healthcare by empowering community-based physicians with the resources and expertise they need to innovate the payment and delivery of care for seniors. The company enables physicians to create their own Medicare-centric globally capitated line of business.

Executives

Jeffrey A. Schwaneke	director	C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Steven Sell	director, officer: CEO & President	C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Benjamin Shaker	officer: Chief Markets Officer	C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Timothy Gertsch	officer: Chief Accounting Officer	C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Silvana Battaglia	director	227 WASHINGTON STREET, CONSHOHOCKEN PA 19428
Cd&r Investment Associates Ix, Ltd.	10 percent owner	MAPLES CORPORATE SERVICES LIMITED, UGLAND HOUSE, GRAND CAYMAN E9 KY101194
Veeral Desai	officer: Chief Strategy & Dev. Officer	C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Benjamin Kornitzer	officer: Chief Med. & Quality Officer	C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
John William Wulf	director	C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Diana Mckenzie	director	METLIFE, 200 PARK AVENUE, NEW YORK NY 10166
Priscilla Kasenchak	officer: Chief Accounting Officer	1111 MARCUS AVENUE, LAKE SUCCESS NY 11042
Michael L Smith	director	C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Theodore Halkias	officer: Chief Business Officer	C/O AGILON HEALTH, INC., 1 WORLD TRADE CENTER, SUITE 2000, LONG BEACH CA 90831
Joan Danieley	officer: Chief Administrative Officer	C/O AGILON HEALTH, INC., 1 WORLD TRADE CENTER, SUITE 2000, LONG BEACH CA 90831
Glenn Sobotka	officer: Chief Accounting Officer	C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723